Bausch + Lomb Multifocal for Astigmatism (kalifilcon A) One-Day Soft (hydrophilic) Contact Lens
Bausch + Lomb, Inc. · Decision date Oct 16, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-16 for K262941, a traditional 510(k) from Bausch + Lomb, Inc. of Rochester, New York, received 08/21/2026. The device is the Bausch + Lomb Multifocal for Astigmatism (kalifilcon A) One-Day Soft (hydrophilic) Contact Lens, classified under regulation 886.5925 as Lenses, Soft Contact, Daily Wear, product code LPL, with subsequent product code MVN and the Ophthalmic review panel. SESE means clearance to market, not PMA approval.
The available FDA PDF excerpt states the lens is indicated for the daily wear correction of, but the excerpt ends there, so the full indication wording is not established here. The excerpt also notes review of the 510(k) against legally marketed predicate devices without naming them. The page lists no third-party review, no combination product status and no authorized predetermined change control plan. Clinical data, labeling details and the predicate identity remain unknown from these excerpts.
The page was last updated 10/26/2026. No supplement type or reason is recorded for this record.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Ophthalmic
- Decision date
- Oct 16, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262941
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Bausch + Lomb, Inc.
- Product code
- LPL
- Decision code
- SESE
- Decision date
- Oct 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Lenses, Soft Contact, Daily Wear.
- Applicant
- Bausch + Lomb, Inc.
- Product code
- LPL
- FDA device class
- 2
FDA decision timeline
K262941 received
Application receipt date recorded by FDA.
K262941 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code LPL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| St. shine Optical Co., Ltd. | 510(k) clearance | Oct 28, 2026 | FDA | |
| Visco Vision, Inc. | 510(k) clearance | Oct 23, 2026 | FDA | |
| Menicon Co, Ltd. | 510(k) clearance | Sep 17, 2026 | FDA | |
| INTEROJO, Inc. | 510(k) clearance | May 29, 2026 | FDA | |
| Pegavision Corporation | 510(k) clearance | May 21, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Bausch + Lomb, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Rochester, NY
Sources and methodology
- Original FDA record: K262941
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


